Active — Not RecruitingNot Applicable

National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)

France628 participantsStarted 2016-03-22

Plain-language summary

The purpose of this study is to constitute the French largest Aggressive fibromatosis cohort.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Incident Case of aggressive fibromatosis in France, diagnosed after 01/01/2016 * Confirmed diagnosis by the French anatomopathological diagnosis network (including search for mutation of the β-Catenin Gene, CTNNB1) * Affiliation to the National Health System * Informed consent signed (both parents signature for non adult patients) Exclusion Criteria: * Administrative or legal measure of liberty privation * Patient not able to give consent or unwilling to provide consent

What they're measuring

Incident cases of aggressive fibromatosis, diagnosed after 01/01/2016 in France

Timeframe: through study completion, an average of 5 years

Trial details

NCT IDNCT02867033

SponsorCentre Oscar Lambret

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2030-11

View on ClinicalTrials.gov More Aggressive Fibromatosis trials